Keyphrases
Adipose Tissue
33%
Anti-inflammation
33%
Bone Morphogenetic protein-7 (BMP-7)
100%
Cartilage
100%
Cartilage Degeneration
33%
Clinical Trials
33%
Clinically Significant
33%
Co-treatment
66%
Combined Treatment
66%
Disease-modifying Osteoarthritis Drugs (DMOADs)
33%
Fibrous Tissue
66%
Genetic Pathways
33%
Glycosaminoglycans
33%
Human Mesenchymal Stem Cells (hMSCs)
33%
Inflammation
33%
Interleukin-1β
33%
Joint Disease
66%
Joint Inflammation
100%
Joint System
33%
Knee Joint
33%
Microphysiological Systems
100%
Model Limit
33%
Novel Treatments
33%
Nuclear factor-κB
66%
Oligodeoxynucleotide
100%
Osteoarthritis
100%
Osteoarthritis Model
33%
Osteochondral
66%
Synovitis
33%
Therapeutic Efficacy
33%
Therapeutic Outcome
33%
Tissue Analogs
33%
Medicine and Dentistry
Adipose Tissue
20%
Arthritis
100%
Arthropathy
40%
Bone Marrow Derived Mesenchymal Stem Cell
20%
Bone Morphogenetic Protein
60%
Cartilage Degeneration
20%
Clinical Study
20%
Clinical Trial
20%
Combination Therapy
20%
Disease
20%
Glycosaminoglycan
20%
Interleukin 1
20%
Knee Joint
20%
Nuclear Factor
40%
Oligodeoxynucleotide
60%
Osteoarthritis
100%
Synovitis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Anti-Inflammation
20%
Arthritis
100%
Arthropathy
40%
Bone Morphogenetic Protein
60%
Cartilage Degeneration
20%
Clinical Study
20%
Clinical Trial
20%
Combination Therapy
20%
Disease
20%
Glycosaminoglycan
20%
Inflammation
20%
Interleukin 1
20%
Nuclear Factor
40%
Oligodeoxynucleotide
60%
Osteoarthritis
100%
Synovitis
20%
Immunology and Microbiology
Adipose Tissue
20%
Arthritis
100%
Arthropathy
40%
Bone Marrow Derived Mesenchymal Stem Cell
20%
Bone Morphogenetic Protein
60%
Cartilage
100%
Interleukin 1
20%
Knee
20%
Osteoarthritis
100%
Synovitis
20%
Biochemistry, Genetics and Molecular Biology
Bone Marrow-Derived Mesenchymal Stem Cells
33%
Bone Morphogenetic Protein
100%
Clinical Study
33%
Clinical Trial
33%
Genetics
33%
Glycosaminoglycan
33%
Interleukin-1
33%